CILO-CLOP Trial: Cilostazol Versus Clopidogrel in Acute Moderate and Moderate-to-Severe Ischemic Stroke: A Randomized Controlled Multicenter Trial. [PDF]
Zeinhom MG+12 more
europepmc +1 more source
Optimal duration of dual antiplatelet therapy for minor stroke within 72 hours of symptom onset: a prospective cohort study. [PDF]
Liu T+19 more
europepmc +1 more source
Cilostazole versus clopidogrel in acute large-vessel moderate and moderate-to-severe ischemic stroke: a randomized controlled trial. [PDF]
Ahmed SR+14 more
europepmc +1 more source
Short-term effects of rivaroxaban combined with aspirin in the treatment of lower limb arterial atherosclerosis occlusion with stent placement: A retrospective study. [PDF]
Chen J, Chen F, Lu C, Yi S, Xiong W.
europepmc +1 more source
Role of thromboelastography in predicting stroke risk after endovascular treatment for symptomatic intracranial atherosclerotic stenosis. [PDF]
Zhou B+11 more
europepmc +1 more source
Advanced QbD-Based Process Optimization of Clopidogrel Tablets with Insights into Industrial Manufacturing Design. [PDF]
Bak YW+6 more
europepmc +1 more source
Investigating the pharmacological mechanisms of clopidogrel for carotid stenosis treatment based on network pharmacology and molecular docking techniques. [PDF]
Wang X, Lu H, Xie J, Zhang C.
europepmc +1 more source
Exploring the relationship of platelet aggregation function with efficacy and safety outcomes following the administration of prasugrel and clopidogrel in patients with thrombotic stroke: a post hoc analysis of PRASTRO pooled studies. [PDF]
Kimura K+6 more
europepmc +1 more source
Ticagrelor or dipyridamole plus aspirin may be a promising antiplatelet therapy in patients with minor stroke or transient ischemic attack: a bayesian network meta-analysis. [PDF]
Qin S+5 more
europepmc +1 more source